Rezolute, Inc. SEC filings RZLT
Rezolute, Inc. has 755 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form 10-K, was filed on Sep 24, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 12, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2026 | Oct 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 28, 2026 | — |
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| DEF 14A | Proxy statement | Oct 21, 2026 | Dec 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 7, 2026 | Dec 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 10-K | Annual report | Sep 24, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 24, 2026 | Sep 24, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 12, 2026 | — |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jul 7, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2026 | Jun 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 4, 2026 | May 1, 2026 |
| 4 | Insider transaction | Mar 31, 2026 | Mar 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 10-Q | Quarterly report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 30, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2026 | Jan 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 18, 2025 | — |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 15, 2025 |
| S-3ASR | Automatic shelf registration | Dec 5, 2025 | — |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| S-8 | Employee stock plan registration | Nov 21, 2025 | — |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change
|
Oct 21, 2025 | Oct 17, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 17, 2025 | — |
| DEF 14A | Proxy statement | Oct 7, 2025 | Nov 19, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 22, 2025 | — |
| 10-K | Annual report | Sep 17, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Sep 17, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 4 | Insider transaction | Aug 27, 2025 | Aug 18, 2025 |
| 3 | Initial insider ownership | Aug 27, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Aug 20, 2025 | Aug 18, 2025 |
| EFFECT | Filing | Aug 8, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| CORRESP | Letter to the SEC | Aug 1, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 18, 2025 | Jul 15, 2025 |
| S-3 | Shelf registration | Jul 17, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 10, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 13, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jun 13, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 23, 2025 | Apr 23, 2025 |
| 424B5 | Prospectus supplement | Apr 23, 2025 | — |
| 424B5 | Prospectus supplement | Apr 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Mar 31, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 25, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 25, 2025 |
| 3 | Initial insider ownership | Mar 26, 2025 | Mar 25, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 7, 2025 | — |
| 4 | Insider transaction | Feb 20, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Jun 25, 2024 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 10-Q | Quarterly report | Feb 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2025 | Feb 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 7, 2025 |
| S-8 | Employee stock plan registration | Dec 30, 2024 | — |
| 4 | Insider transaction | Dec 18, 2024 | Dec 18, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 10, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| DEFA14A | Additional proxy material | Oct 21, 2024 | — |
| DEF 14A | Proxy statement | Oct 21, 2024 | Dec 5, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 10, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 24, 2024 |
| 4 | Insider transaction | Sep 24, 2024 | Sep 23, 2024 |
| 10-K | Annual report | Sep 19, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| EFFECT | Filing | Aug 14, 2024 | — |
| CORRESP | Letter to the SEC | Aug 13, 2024 | — |
| S-3/A | Filing | Aug 12, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2024 | — |
| S-3 | Shelf registration | Aug 5, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 28, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 27, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 14, 2024 | Jun 13, 2024 |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| 4 | Insider transaction | Jun 14, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 14, 2024 |
| 424B5 | Prospectus supplement | Jun 13, 2024 | — |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2024 | May 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2024 | May 16, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2024 | Apr 23, 2024 |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 16, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Oct 15, 2021 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| 4/A | Filing | Mar 18, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Material agreement, Auditor change
|
Mar 14, 2024 | Mar 8, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Jul 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2024 | Mar 6, 2024 |
| SC 13G | Ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 11, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 8, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 23, 2024 |
| 8-K |
Current report
Other events
|
Feb 22, 2024 | Feb 21, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Feb 20, 2024 | Feb 16, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 10-Q | Quarterly report | Feb 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Jan 29, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 3 | Initial insider ownership | Jan 25, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| 4 | Insider transaction | Jan 25, 2024 | Jan 23, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2023 | Dec 13, 2023 |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| S-3/A | Filing | Nov 22, 2023 | — |
| 8-K |
Current report
Listing notice
|
Nov 22, 2023 | Nov 21, 2023 |
| UPLOAD | Letter from the SEC | Nov 20, 2023 | — |
| S-3 | Shelf registration | Nov 14, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 18, 2023 | Oct 17, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RZLT (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Redwood City, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509261
- Former names
- AntriaBio, Inc. (until Dec 7, 2017); FITS MY STYLE INC (until Jan 11, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.